Company page
Urogen Pharma Ltd.
Urogen Pharma Ltd. is a public company listed under the ticker URGN, operating in the American market. The company has a market capitalization of approximately $1.64 billion. Urogen focuses on developing innovative therapies for urological diseases, aiming to improve patient outcomes.
- Ticker
- URGN:NASDAQ
- Asset type
- Stock
- Market cap
- $1.64B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD